Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) has seen 3.44 million shares traded in the last trading session. The company, currently valued at $15.83M, closed the last
During the last session, Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT)’s traded shares were 1.07 million. At the end of the trading day, the stock’s price was
In the last trading session, 1.08 million shares of the Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) were traded. Most recently the company’s share price was $0.28,
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT)’s traded shares stood at 2.04 million during the last session. At the close of trading, the stock’s price was $0.28,
In the last trading session, 1.97 million Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) shares changed hands as the company’s beta touched 0. With the company’s per
In last trading session, Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) saw 1.43 million shares changing hands with its beta currently measuring 0. Company’s recent per share
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) has seen 1.37 million shares traded in the last trading session. The company, currently valued at $19.81M, closed the last
In the last trading session, 2.78 million shares of the Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) were traded. Most recently the company’s share price was $0.40,
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT)’s traded shares stood at 3.02 million during the last session. At the close of trading, the stock’s price was $0.41,
In the last trading session, 1.35 million Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) shares changed hands as the company’s beta touched 0. With the company’s per